Stock Screener App

Frei -

Installieren

9.60

2.24% 0.21

Leonabio Inc (LONA)

Überblick Nachrichten Preisverlauf Forum Prognose

Leonabio Inc Aktie (LONA) Neueste Nachrichten

Form 4 LeonaBio Inc For: 10 July By Investing.com - Investing.com Nigeria

LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role - Stock Titan

Form 4 LeonaBio Inc For: 9 July By Investing.com - Investing.com Nigeria

LeonaBio (LONA) director entities receive 28,000 stock options grant - Stock Titan

LeonaBio (LONA) Gains 5.85% as Biotech Stock Approaches Key ResistanceIPO Entry Watch - dars.gov.et

LONA Q1 2026 Earnings: EPS Surprise of 32% Powers 5.85% Share RallyEPS Estimate Trend - dars.gov.et

LeonaBio Inc. (LONA) Declines 1.6% Amid Mixed Technical SignalsLow Vol ETF - dars.gov.et

LeonaBio, Inc.(NasdaqCM: LONA) added to Russell Microcap Growth Benchmark Index - marketscreener.com

LeonaBio, Inc.(NasdaqCM: LONA) added to Russell 3000E Growth Benchmark - marketscreener.com

LeonaBio, Inc.(NasdaqCM: LONA) added to Russell Microcap Index - marketscreener.com

LeonaBio, Inc.(NasdaqCM: LONA) added to Russell 3000E Index - marketscreener.com

LONALeonaBio Inc Dividends - Finviz

LONA SEC FilingsLeonaBio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Enterprise value to EBIT forward of LeonaBio, Inc. – NASDAQ:LONA - TradingView

Price to sales forward of LeonaBio, Inc. – NASDAQ:LONA - TradingView

Number of shareholders of LeonaBio, Inc. – NASDAQ:LONA - TradingView

LeonaBio, Inc. Actuals & Estimates (NASDAQ:LONA) - TradingView

LONA Forecast — Price Target — Prediction for 2027 - TradingView

Form 4 LeonaBio Inc For: 24 June By Investing.com - Investing.com South Africa

LeonaBio (LONA) director Fred Callori granted 2,333 stock options - Stock Titan

LeonaBio (LONA) director receives grant of 28,000 stock options at $8.35 - Stock Titan

[Form 4] LeonaBio, Inc. Insider Trading Activity - Stock Titan

LeonaBio (LONA) director receives 2,333 stock options at $8.35 strike - Stock Titan

LeonaBio (LONA) director receives 28,000 stock options at $8.35 exercise price - Stock Titan

LeonaBio (LONA) director awarded 28,000 stock options at $8.35 strike - Stock Titan

LeonaBio (LONA) director receives stock option grant for 28,000 shares - Stock Titan

LeonaBio (LONA) grants 28,000 stock options to director Barbara Kosacz - Stock Titan

Grant Pickering of LeonaBio (LONA) awarded 28,000 stock options at $8.35 - Stock Titan

LeonaBio Inc. (LONA) Edges Higher as Biotech Sector Shows Renewed InterestChange of Character - dars.gov.et

LeonaBio Shareholders Approve Directors, Auditor and Compensation - TipRanks

LeonaBio (NASDAQ: LONA) shareholders approve directors, EY auditor and executive pay cadence - Stock Titan

LeonaBio Ord Shs (LONA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

LeonaBio Ord Shs (LONA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

LeonaBio Ord Shs (LONA) Institutional Confidence - TradingKey

LONA Q1 2026 Earnings: EPS Surprises Above Estimates Amid Pre-Revenue PhaseGuidance Accuracy Score - newsline.com

LONA Q1 2026 Earnings: Narrowed Loss Exceeds Expectations as Cost Discipline ContinuesEarnings Trend Analysis - newsline.com

LeonaBio (LONA) Holds Steady Near Support as Sector Sentiment WeighsLow Beta Factor - newsline.com

LeonaBio names brelgometon as INN for ALS drug candidate ATH-1105 - Investing.com UK

LeonaBio names brelgometon as INN for ALS drug candidate ATH-1105 By Investing.com - Investing.com South Africa

LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit - The Manila Times

Experimental ALS pill brelgometon targets Phase 2 trial in 2026 - Stock Titan

LONA Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Pipeline Despite Market HeadwindsMargin Improvement Report - The Legal Advocate

LeonaBio Inc. (LONA) Q1 2026 Earnings: Surprise EPS Beat Signals Progress Despite Revenue GapEstimate Uncertainty - The Legal Advocate

LeonaBio Gets $20 Price Target Ahead of June Pipeline Test - Bez Kabli

LeonaBio Inc. (LONA) Rises 1.45% as Shares Approach Key Resistance at $10.3Stock News - The Legal Advocate

LONA Initiated Coverage by Piper Sandler -- Rating Set to Overwe - GuruFocus

LeonaBio to Participate in Upcoming Medical and Industry Meetings in June - GlobeNewswire

Piper Sandler initiates LeonaBio stock with overweight rating - Investing.com

Piper Sandler initiates LeonaBio stock with overweight rating By Investing.com - Investing.com Canada

LeonaBio Inc. (LONA) Q1 2026 Earnings: EPS Surprise Provides Bright Spot Amid Revenue Absence and Stock DeclineCash Flow Report - The Legal Advocate

LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ReactionOperating Income Trends - The Legal Advocate

RPRX

$56.43

2.64%

INSM

$115.61

2.24%

ROIV

$35.97

2.28%

MRNA

$68.27

10.83%

ONC

$298.70

1.36%

RVMD

$186.88

2.22%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters